Meet the Legal Team Fighting the DEA to Save Psychedelic Research – Psychedelics Today
We are grateful to Psychedelics Today for educating the community about the importance of DOI & DOC.
“I have many colleagues who work with these compounds who will testify in the upcoming hearing, and that is only a subset of the research community,” said Elijah Ullman, Chair of SSDP’s Science Policy Council who has been interested in science policy since he was a teen.
Ullman added, “The DEA alleges that DOI and DOC should be placed in Schedule 1 because of their high potential for abuse, but this does not align with over 40 years of data.”
